Clinical trials for lung cancer

129 currently recruiting clinical trials

Phase 1 / Phase 2 Lung cancer
#NCT04585750
Locally Advanced Metastatic TP53 1 2 3 or more
KRAS G12C KRAS non G12C Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Nîmes (Nîmes), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Gustave Roussy (Villejuif) (and 3 more...)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2 Lung cancer
#NCT06162572
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic PDL1 Positive (>= 50%) Systemic Treatment-Naive
ALK EGFR ROS-1 Immunotherapy Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut Paoli-Calmettes (Marseille), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire de Grenoble (La Tronche), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Servier
Phase 1 / Phase 2 Lung cancer
#NCT05937906
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic PDL1 Negative (< 1%) PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) None Systemic Treatment-Naive
ALK EGFR ROS-1
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Centre Georges François Leclerc
Phase 1 / Phase 2 Lung cancer
#NCT06448572
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic 1 2 3 or more Immunotherapy Chemotherapy
ALK BRAF EGFR HER2 MET RET ROS-1
Centre Hospitalier Universitaire de Lille (Lille)
CHU Lille
Phase 1 / Phase 2 Lung cancer
#NCT05592626
NSCLC (Non-Small Cell Lung Cancer) Metastatic MSI/dMMR 1 2 3 or more
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux)
Marengo Therapeutics, Inc.
Phase 1 / Phase 2 Lung cancer
#NCT04626635
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Chemotherapy Targeted therapy
Systemic Treatment-Naive Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital d'instruction des Armées Bégin (Saint-Mandé), Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon) (and 5 more...)
Regeneron Pharmaceuticals
Phase 1 / Phase 2 Lung cancer
#NCT04626635
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic
Systemic Treatment-Naive Immunotherapy
CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Hôpital d'instruction des Armées Bégin (Saint-Mandé), Institut Bergonié (Bordeaux), Centre Léon Bérard (Lyon) (and 5 more...)
Regeneron Pharmaceuticals
Phase 1 / Phase 2 Lung cancer
#NCT04143711
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic HER2 1 2 3 or more Immunotherapy Chemotherapy
Systemic Treatment-Naive
Institut du cancer de Montpellier (Montpellier), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Hôpital Pitié Salpêtrière - AP-HP (Paris), Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille) (and 5 more...)
Dragonfly Therapeutics
Phase 1 / Phase 2
#NCT05544552
Locally Advanced Metastatic FGFR
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), IUCT Oncopôle (Toulouse), Gustave Roussy (Villejuif)
Tyra Biosciences, Inc